As the trade of personal health and medical data expands, it becomes necessary to improve legal frameworks for protecting patient anonymity, handling consent and ensuring the quality of data

For centuries people have been asking, “Why is there something rather than nothing?” Science has not been able to give us an answer so far. We still have to live with the basic statement that “Everything that is is, and it is as long as it keeps its identity, that is, its onticity”, which we may call the “Strong Ontic Principle”.

Enhancing trust in science through public engagement and open, transparent research is vital if we are to avoid descending into a 'post-factual society', according to Carlos Moedas, the European Commissioner for Research, Innovation and Science.

UK scientists have had to fight to stay international before, and they must not stop now

The European Research Council has begun to evaluate the impact of its grants; others should do the same.

Nature and the Nature journals are diversifying their presentation of performance indicators.

How editors conduct peer review, how this process is evolving and whether we can trust the new players entering the field, the responsibilities of reviewers and how to recognize and reward all the effort put in to peer review.

Britain’s vote to leave the European Union is jeopardizing scientists’ funds, collaborations, staff and students; it has left the nation reeling and Europe vulnerable.

With university staff thinking about the start of the next academic year, Robert MacIntosh and Kevin O'Gorman offer some advice to staff due to arrive on campus this autumn.

UK science minister Jo Johnson was poorly received in Manchester, after a low-key speech that several attendees said contrasted sharply with a rather inspirational post-Brexit address from EU research commissioner Carlos Moedas.

How to manage the research-paper deluge? Blogs, colleagues and social media can all help.

Competitive peer review increases innovation, but it has a dark side.

Americans embraced the marketisation of higher education, with profit-making colleges and debt-laden customers. The result has been corruption and failure

Stephen Curry offers a researcher's perspective on the possible outcomes of the Brexit.

New studies on the quality of published research shows we could be wasting billions of dollars a year on bad science, to the neglect of good science projects.

Tech giants moving into health may widen inequalities and harm research, unless people can access and share their data, warn John T. Wilbanks and Eric J.

The story of CRISPR–Cas9 gene editing has tended to focus on a few key players.

Thomson Reuters claims it has “never advocated” the use of the impact factor for the “analysis of individual research artefacts or people”. 

EU funding was a vital lifeline for our world-leading scientific research sector. That, and so much more, has now been blown away

There is such a surplus of Ph.D.s that in the most popular fields, like biomedicine, fewer than one in six reach their goal in academia.

The impact factor is a poor measure of a journal's quality, and academics say it should either be overhauled or done away with entirely.

Social media has swallowed the news – threatening the funding of public-interest reporting and ushering in an era when everyone has their own facts. But the consequences go far beyond journalism.

The focus on impact of published research has created new opportunities for misconduct and fraudsters, says Mario Biagioli.

Senior academic from the university embroiled in the ‘Climategate’ scandal warns how open data can be used irresponsibly to damage science.

If you think Google has a controversial reputation at this point in its business evolution, buckle up because things are really stepping up a gear.

A postdoc job is good for your career, but don't get stuck in an academic cul-de-sac, says Søren-Peter Olesen.

"Science is, indeed, a profoundly social activity": Jeremy Berg's first Science editorial

As science and technology have advanced, it’s become possible to make it personalized as well, giving us the tools to better understand, prevent, and treat everyone’s individual health needs, writes Obama.

Recent studies highlight why policy changes are needed to make science more receptive to novelty, our columnist writes.

John Holdren tells Nature about the highs and lows of nearly eight years in the White House.